Transgene Archives -

Undeterred by two clinical failures for its cancer immunotherapies in 2019, Transgene has kicked off the New Year

Transgene starts trials of ‘digital’ cancer vaccine with NEC

https://pharmaphorum.com/news/transgene-starts-trials-of-digital-cancer-vaccine-with-nec/

South Korean biotech Sillajen was hit hard last week when its oncolytic virus therapy Pexa-Vec failed a phase

Sillajen explains Pexa-Vec trial failure – it was the rescue meds

https://pharmaphorum.com/news/sillajen-explains-pexa-vec-trial-failure-it-was-the-rescue-meds/

Virus-based immunotherapy biotech Transgene is to begin clinical trials of its head and neck cancer drug candidate TG4050

Transgene begins trials of head and neck cancer vaccine

https://pharmaphorum.com/news/transgene-begins-trials-of-head-and-neck-cancer-vaccine/

Transgene